Clinical Trials

Clinical Trials

MyoKardia is currently conducting late-stage clinical studies of mavacamten, an investigational therapeutic being developed for the treatment of obstructive and non-obstructive forms of hypertrophic cardiomyopathy.

Find Mavacamten Clinical Trials

We are also studying MYK-491 in a Phase 2 clinical trial of patients with stable systolic heart failure/dilated cardiomyopathy (DCM).

Find MYK-491 Clinical Trials

To reach a member of our clinical development team about trial participation, please contact us at medinfo@myokardia.com. Responses will be given within 10 days.